age float64 18 102 | sex stringclasses 2
values | hospdead int64 0 1 | slos int64 3 343 | dzgroup stringclasses 8
values | dzclass stringclasses 4
values | num.co int64 0 9 | edu float64 0 31 ⌀ | income stringclasses 4
values | scoma float64 0 100 ⌀ | charges float64 1.17k 1.44M ⌀ | totcst float64 0 633k ⌀ | totmcst float64 -102.72 711k ⌀ | avtisst float64 1 83 ⌀ | race stringclasses 5
values | sps float64 0.2 99.2 ⌀ | aps float64 0 143 ⌀ | surv2m float64 0 0.97 ⌀ | surv6m float64 0 0.95 ⌀ | hday int64 1 148 | diabetes int64 0 1 | dementia int64 0 1 | ca stringclasses 3
values | prg2m float64 0 1 ⌀ | prg6m float64 0 1 ⌀ | dnr stringclasses 3
values | dnrday float64 -88 285 ⌀ | meanbp float64 0 195 ⌀ | wblc float64 0 200 ⌀ | hrt float64 0 300 ⌀ | resp float64 0 90 ⌀ | temp float64 31.7 41.7 ⌀ | pafi float64 12 890 ⌀ | alb float64 0.4 29 ⌀ | bili float64 0.1 63 ⌀ | crea float64 0.1 21.5 ⌀ | sod float64 110 181 ⌀ | ph float64 6.83 7.77 ⌀ | glucose float64 0 1.09k ⌀ | bun float64 1 300 ⌀ | urine float64 0 9k ⌀ | adlp float64 0 7 ⌀ | adls float64 0 7 ⌀ | sfdm2 stringclasses 5
values | adlsc float64 0 7.07 | event_times int64 3 2.03k | event_indicators int64 0 1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
31.45499 | female | 0 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | under $11k | 0 | 12,363 | 8,496.1641 | 6,908.94922 | 7.5 | black | 26.796875 | 38 | 0.868896 | 0.822998 | 1 | 1 | 0 | no | 0.6 | 0.5 | no dnr | 7 | 131 | 11 | 103 | 10 | 37.69531 | 96 | 3 | 1.299805 | 2.699707 | 144 | 7.429688 | 392 | 53 | 924 | null | null | adl>=4 (>=5 if sur) | 2.064941 | 198 | 1 |
35.60797 | female | 0 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 0 | 55,312 | 30,751.875 | 35,774.4062 | 23 | white | 20.5 | 24 | 0.912964 | 0.880981 | 1 | 0 | 0 | no | 1 | 0.95 | no dnr | 19 | 139 | null | 106 | 28 | 35.59375 | 219.03125 | 3.299805 | 0.5 | 8.398438 | 137 | 7.449219 | 92 | 53 | 325 | null | 0 | no(M2 and SIP pres) | 0 | 685 | 0 |
76.18896 | female | 0 | 3 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 4,601 | 2,396.1289 | 2,195.38867 | null | white | 13 | 8 | 0.856934 | 0.763916 | 1 | 0 | 1 | yes | null | null | dnr before sadm | -1 | 65 | 12.5 | 60 | 30 | 37.69531 | 126.51562 | 3.099609 | null | 1.5 | 140 | 7.429688 | 210 | 52 | 800 | null | null | null | 4.192383 | 685 | 0 |
83.07495 | female | 0 | 17 | Coma | Coma | 1 | 14 | $11-$25k | 37 | 25,394 | 15,203.2812 | 15,030.9531 | 13.666664 | white | 17.097656 | 18 | 0.371948 | 0.297974 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr before sadm | -1 | 38 | 39.398438 | 52 | 14 | 38.69531 | 354 | 2.799805 | 0.399963 | 7.799805 | 130 | 7.329102 | 63 | 63 | 0 | null | 2 | <2 mo. follow-up | 2 | 29 | 1 |
81.00995 | male | 0 | 10 | Lung Cancer | Cancer | 1 | 16 | null | 0 | 12,735 | 6,927.9883 | 7,069.69922 | 14 | white | 16 | 24 | 0.690918 | 0.399963 | 1 | 0 | 0 | metastatic | 0.1 | 0 | dnr after sadm | 2 | 72 | 10.599609 | 103 | 12 | 36.39844 | 241.65625 | 2.699707 | 0.399963 | 0.699951 | 143 | 7.40918 | 292 | 26 | 1,375 | null | 3 | <2 mo. follow-up | 3 | 16 | 1 |
52.11798 | male | 0 | 37 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 141,717 | 95,230 | 80,719.75 | 39 | black | 24.097656 | 43 | 0.824951 | 0.765991 | 3 | 1 | 0 | no | 0.3 | 0.3 | no dnr | 37 | 53 | 6.5 | 60 | 24 | 36.59375 | 161.21875 | 2.799805 | null | 0.699951 | 135 | 7.469727 | 99 | 7 | 1,275 | null | null | null | 2.054688 | 682 | 0 |
89.547 | female | 0 | 12 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 16,186 | 8,523.2422 | 8,228.25781 | 15.5 | white | 21.597656 | 42 | 0.746948 | 0.600952 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 12 | 75 | 14 | 74 | 24 | 35.89844 | 276.1875 | null | null | 1.5 | 136 | 7.449219 | 106 | 22 | 3,750 | 1 | 3 | adl>=4 (>=5 if sur) | 3 | 141 | 1 |
90.03094 | male | 0 | 14 | CHF | COPD/CHF/Cirrhosis | 3 | null | >$50k | 0 | 19,286 | 9,880.3359 | 10,211.0078 | 7 | white | 17.597656 | 23 | 0.80896 | 0.690918 | 1 | 0 | 0 | no | 0.7 | 0.6 | dnr after sadm | 6 | 83 | 11.298828 | 100 | 20 | 35.39844 | null | 2.099609 | 3.699707 | 0.899902 | 131 | null | 96 | 11 | 750 | 0 | 0 | <2 mo. follow-up | 0 | 32 | 1 |
78.00696 | female | 0 | 9 | Colon Cancer | Cancer | 2 | 8 | $11-$25k | 0 | 9,633 | 5,673.2227 | 5,506.94922 | 13.5 | white | 28.699219 | 10 | 0.545898 | 0.222992 | 1 | 0 | 0 | metastatic | 0.9 | 0.9 | no dnr | 9 | 57 | 11.699219 | 70 | 10 | 38.19531 | 176 | 2.299805 | 0.5 | 2.699707 | 132 | 7.359375 | 141 | 63 | 2,170 | 1 | 1 | no(M2 and SIP pres) | 1 | 212 | 1 |
74.771 | female | 1 | 29 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | $25-$50k | 0 | 144,316 | 96,597.3125 | 80,722.375 | 39.5 | hispanic | 33.796875 | 52 | 0.482971 | 0.363953 | 1 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 15 | 54 | 117 | 118 | 30 | 38.19531 | null | null | null | 0.5 | 137 | 7.429688 | 105 | 23 | 930 | null | 0 | <2 mo. follow-up | 0 | 29 | 1 |
79.82794 | female | 0 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | null | 0 | 16,884 | 9,903.6406 | 9,306.90625 | 16 | white | 19.898438 | 33 | 0.814941 | 0.753906 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 10 | 57 | 8.798828 | 60 | 20 | 38.29688 | 141.65625 | 3 | 1 | 1.199951 | 137 | 7.379883 | 129 | 17 | 4,600 | 0 | null | no(M2 and SIP pres) | 0.494751 | 680 | 0 |
48.55899 | male | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | $25-$50k | 0 | 4,980 | 2,690.5996 | 3,391.92969 | 9 | white | 18.199219 | 17 | 0.891968 | 0.819946 | 1 | 0 | 0 | yes | null | null | no dnr | 4 | 100 | 3.699707 | 60 | 25 | 36.09375 | null | null | null | 2.799805 | 143 | null | 89 | 70 | 1,600 | null | null | no(M2 and SIP pres) | 2.184082 | 680 | 0 |
68.65399 | male | 0 | 38 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 15 | null | 0 | 98,707 | null | null | 34.5 | black | 27.398438 | 32 | 0.737915 | 0.655884 | 1 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 38 | 60 | 10 | 110 | 12 | 38.5 | 180 | 2.299805 | 0.599976 | 2.199707 | 148 | 7.359375 | 106 | 46 | 2,044 | null | 0 | adl>=4 (>=5 if sur) | 0 | 158 | 1 |
20.05199 | female | 0 | 13 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 13 | under $11k | 0 | 27,570 | 16,774.4219 | 15,263.875 | 11.5 | asian | 28.597656 | 37 | 0.866943 | 0.779907 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 13 | 82 | 17 | 120 | 30 | 38.09375 | 135 | null | null | 1 | 137 | 7.449219 | 373 | 30 | 1,500 | 0 | 0 | null | 0 | 678 | 0 |
51.86298 | male | 0 | 49 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 193,178 | 116,287.625 | 102,016.438 | 48 | white | 33.695313 | 62 | 0.612915 | 0.506958 | 11 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 49 | 63 | 4.799805 | 38 | 26 | 36.19531 | null | null | 0.699951 | 1.899902 | 140 | null | 98 | 78 | 1,890 | null | 0 | no(M2 and SIP pres) | 0 | 677 | 0 |
85.85895 | male | 0 | 10 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 14,731 | 8,202.5156 | 7,041.92969 | 16.5 | white | 20.796875 | 24 | 0.726929 | 0.573975 | 1 | 0 | 1 | no | null | null | dnr after sadm | 1 | 73 | 2.599609 | 180 | 4 | 36.59375 | 140 | 2.299805 | 4.399414 | 2.699707 | 136 | 7.359375 | 97 | 49 | 750 | null | 7 | adl>=4 (>=5 if sur) | 7 | 677 | 0 |
72.24597 | female | 0 | 7 | Lung Cancer | Cancer | 4 | 12 | $11-$25k | 0 | 10,505 | 5,559.7383 | 5,308.29688 | 7 | white | 20.296875 | 41 | 0.615967 | 0.301941 | 1 | 1 | 0 | metastatic | 0.8 | 0.6 | no dnr | 7 | 77 | 8.199219 | 73 | 8 | 37.69531 | 165 | null | null | 1 | 140 | 7.429688 | 102 | 22 | 4,000 | 0 | 0 | <2 mo. follow-up | 0 | 27 | 1 |
70.26996 | female | 0 | 16 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $25-$50k | 0 | 15,786 | 9,205.1953 | 8,086.22656 | 12 | white | 21 | 26 | 0.792969 | 0.667969 | 1 | 1 | 0 | yes | 0.6 | 0.5 | dnr after sadm | 5 | 131 | 13.099609 | 120 | 7 | 38 | 240.8125 | null | 0.599976 | 2.5 | 143 | 7.269531 | 114 | 52 | 399 | 2 | 0 | null | 0 | 259 | 1 |
74.87195 | female | 0 | 4 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 4,868 | 2,726.8789 | 2,120.68945 | 7 | white | 15.398438 | 14 | 0.715942 | 0.436951 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 112 | 10.699219 | 118 | 40 | 39.19531 | 266.625 | 2.399902 | 1.799805 | 1.699951 | 141 | 7.459961 | 144 | 14 | 3,100 | null | null | <2 mo. follow-up | 2.908691 | 5 | 1 |
59.65198 | male | 0 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 10 | $11-$25k | 0 | 70,523 | 37,017.0938 | 33,704.9688 | 34.333313 | white | 22 | 29 | 0.829956 | 0.771973 | 3 | 1 | 0 | no | null | null | no dnr | 17 | 123 | 9.099609 | 80 | 20 | 37.59375 | 433.3125 | 3.299805 | 0.899902 | 5.199219 | 122 | 7.289062 | 943 | 64 | null | null | null | no(M2 and SIP pres) | 2.557129 | 675 | 0 |
66.34595 | female | 0 | 11 | COPD | COPD/CHF/Cirrhosis | 3 | 14 | >$50k | 0 | 12,506 | 6,952.1836 | 8,685.125 | 11.5 | white | 13.898438 | 27 | 0.887939 | 0.812988 | 1 | 0 | 0 | yes | 1 | 1 | no dnr | 11 | 108 | 7.5 | 114 | 8 | 38.39844 | 185 | 3 | null | 0.599976 | 139 | 7.40918 | 75 | 9 | 4,895 | 1 | 2 | no(M2 and SIP pres) | 2 | 675 | 0 |
58.60898 | female | 0 | 24 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 76,228 | 58,941.125 | 48,895 | 30 | white | 38.796875 | 49 | 0.584961 | 0.391968 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 24 | 83 | 14.599609 | 80 | 20 | 36.69531 | 412 | 3.899902 | 0.299988 | 0.899902 | 146 | 7.329102 | 124 | 31 | null | null | 4 | no(M2 and SIP pres) | 4 | 674 | 1 |
83.13794 | female | 0 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 9 | 13,636 | 7,885.5391 | 6,766.62891 | 12 | white | 22.296875 | 46 | 0.738892 | 0.657959 | 1 | 0 | 1 | no | 0.95 | 0.8 | no dnr | 10 | 75 | null | 67 | 20 | 36.19531 | null | null | null | 1.399902 | 136 | null | 108 | 17 | 1,475 | null | null | adl>=4 (>=5 if sur) | 5.370117 | 326 | 1 |
93.89496 | male | 0 | 7 | COPD | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 8,276 | 4,589.8164 | 5,258.36719 | 4 | white | 18.597656 | 18 | 0.636963 | 0.455994 | 1 | 0 | 0 | yes | 0.65 | 0.5 | no dnr | 7 | 117 | 7.199219 | 100 | 20 | 38.69531 | 420 | 4.199219 | 0.5 | 0.799927 | 132 | 7.539062 | 133 | 11 | 1,200 | null | null | null | 4.414063 | 114 | 1 |
63.55899 | male | 0 | 4 | COPD | COPD/CHF/Cirrhosis | 2 | 6 | under $11k | 0 | 3,814 | 2,211.6289 | 2,215.64844 | 9 | white | 14.699219 | 26 | 0.91394 | 0.85498 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 4 | 113 | 12.099609 | 80 | 20 | 36.69531 | null | 3.599609 | 1.199951 | 1.599854 | 140 | null | 110 | 51 | null | 3 | null | no(M2 and SIP pres) | 2.510742 | 670 | 0 |
88.10699 | male | 0 | 11 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 11,812 | 6,656.2422 | 6,744.65625 | 11 | white | 21.597656 | 20 | 0.753906 | 0.610962 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 11 | 123 | 17.898438 | 70 | 12 | 36.79688 | 160 | 2.199707 | null | 1.899902 | 148 | 7.389648 | 362 | 52 | 2,360 | 1 | 1 | no(M2 and SIP pres) | 1 | 670 | 0 |
88.65198 | male | 1 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 0 | 34,155 | 21,667.0938 | 19,497.7656 | 31 | white | 38.296875 | 54 | 0.339966 | 0.223999 | 1 | 1 | 1 | no | 0.2 | 0.1 | dnr after sadm | 1 | 107 | 12.398438 | 80 | 25 | 36.09375 | 272 | null | 0.599976 | 2.099609 | 144 | 7.319336 | 103 | 50 | 1,400 | null | null | <2 mo. follow-up | 6.161133 | 12 | 1 |
78.18195 | female | 0 | 13 | Lung Cancer | Cancer | 2 | 11 | under $11k | 9 | 11,763 | 7,217.9141 | 6,539.1875 | 11 | white | 32.5 | 19 | 0.208984 | 0.021 | 1 | 0 | 0 | metastatic | 0.2 | 0.05 | dnr after sadm | 1 | 97 | 7.799805 | 80 | 25 | 36.09375 | 460 | null | null | 1.399902 | 136 | 7.469727 | 184 | 39 | 1,250 | null | 6 | <2 mo. follow-up | 6 | 27 | 1 |
76.01398 | male | 0 | 7 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 10,143 | 5,317.5781 | 5,798.20703 | 7 | white | 20.097656 | 19 | 0.806885 | 0.68689 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 83 | 24.699219 | 80 | 15 | 36.09375 | null | 2.599609 | 0.699951 | 0.799927 | 134 | null | 148 | 11 | 982 | 1 | null | no(M2 and SIP pres) | 1.166748 | 669 | 0 |
91.71796 | female | 0 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 6 | under $11k | 0 | 52,128 | 38,784.875 | 30,594.6875 | 26.333328 | white | 25.5 | 57 | 0.645996 | 0.544922 | 2 | 1 | 0 | no | 0.7 | 0.6 | dnr after sadm | 11 | 43 | 15.5 | 113 | 16 | 37.79688 | 154 | 1.899902 | 0.099991 | 0.899902 | 146 | 7.299805 | 186 | 14 | 1,338 | null | 2 | adl>=4 (>=5 if sur) | 2 | 668 | 0 |
60.78 | male | 0 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | >$50k | 0 | 46,709 | 28,562.625 | 26,098.1562 | 13.333328 | white | 23.597656 | 49 | 0.748901 | 0.669922 | 4 | 0 | 0 | yes | 0.75 | 0.75 | no dnr | 14 | 59 | 10.099609 | 78 | 28 | 37.89844 | 150 | 3.699707 | 0.699951 | 1 | 142 | 7.459961 | 114 | 26 | 2,064 | 0 | 0 | no(M2 and SIP pres) | 0 | 668 | 0 |
48.87299 | female | 0 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 54,664 | 28,733.1094 | 32,420.1562 | 24 | white | 22.699219 | 32 | 0.845947 | 0.792969 | 4 | 0 | 0 | no | 0.98 | 0.98 | no dnr | 9 | 104 | 9.398438 | 108 | 22 | 36.59375 | null | null | null | 1.299805 | 140 | null | 133 | 23 | 2,990 | 0 | 0 | no(M2 and SIP pres) | 0 | 392 | 1 |
49.45398 | female | 0 | 4 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 12,241 | 6,169.6445 | 2,776.16992 | 11 | white | 9.199219 | 12 | 0.853882 | 0.67688 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 4 | 49 | 5.699219 | 107 | 28 | 38.89844 | 287.5 | null | 0.599976 | 1.399902 | 142 | 7.429688 | 110 | 35 | 2,710 | 0 | null | no(M2 and SIP pres) | 0.494751 | 664 | 0 |
75.33698 | male | 1 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 30,832 | 21,063.1719 | 20,832.3438 | 46.5 | white | 41.59375 | 57 | 0.333984 | 0.218994 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 2 | 72 | 15.099609 | 128 | 14 | 36.29688 | null | 2 | 4.099609 | 0.599976 | 131 | null | 164 | 10 | 1,200 | null | 6 | <2 mo. follow-up | 6 | 7 | 1 |
36.44897 | female | 0 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 9,396 | 6,253.5547 | 6,516.72656 | 12 | white | 26.199219 | 30 | 0.862915 | 0.814941 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 6 | 60 | 29.796875 | 150 | 12 | 36.09375 | 66 | 1.699951 | 1.099854 | 0.799927 | 145 | 7.329102 | 309 | 11 | 965 | 0 | null | null | 0.494751 | 661 | 0 |
74.48297 | male | 1 | 31 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 55 | 53,352 | 38,328.8125 | 35,363 | 18.5 | white | 22.898438 | 45 | 0.48999 | 0.371948 | 2 | 0 | 0 | yes | null | 0 | dnr after sadm | 1 | 57 | 5 | 80 | 20 | 36.29688 | 261.875 | 2.799805 | null | 1 | 144 | 7.389648 | 105 | 9 | null | null | 0 | <2 mo. follow-up | 0 | 31 | 1 |
90.84998 | female | 0 | 8 | CHF | COPD/CHF/Cirrhosis | 5 | 16 | $25-$50k | 0 | 13,773 | 7,660.4609 | 7,365.83984 | 17 | white | 18 | 30 | 0.750977 | 0.60791 | 1 | 1 | 0 | yes | null | null | no dnr | 8 | 80 | 16.898438 | 80 | 20 | 36.09375 | 300 | 3.299805 | 1.099854 | 1.099854 | 133 | 7.459961 | 158 | 47 | 500 | 1 | 0 | no(M2 and SIP pres) | 0 | 369 | 1 |
58.70999 | male | 0 | 21 | Lung Cancer | Cancer | 2 | null | null | 0 | 46,753 | 22,374.1719 | 26,309.3594 | 14.333328 | white | 22.597656 | 20 | 0.598999 | 0.280945 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 21 | 103 | 6.699219 | 70 | 20 | 35.59375 | null | null | null | 2.299805 | 138 | null | 151 | 79 | 3,050 | 6 | null | null | 4.527344 | 231 | 1 |
79.76495 | female | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 4,730 | 2,543.9805 | 2,328.37891 | 9 | white | 22.097656 | 43 | 0.782959 | 0.652954 | 1 | 1 | 0 | no | null | null | no dnr | 4 | 77 | 3.5 | 90 | 20 | 37.79688 | 290.4375 | null | null | 0.599976 | 143 | 7.509766 | 107 | 11 | null | null | null | no(M2 and SIP pres) | 2.429688 | 660 | 0 |
61.133 | male | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $11-$25k | 0 | 4,455 | 2,464.0703 | 2,166.2793 | 7 | white | 20.898438 | 26 | 0.863892 | 0.773926 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 4 | 60 | 16.898438 | 120 | 12 | 38.39844 | 186 | null | null | 1.199951 | 138 | 7.429688 | 196 | 12 | 1,138 | 0 | null | no(M2 and SIP pres) | 0.494751 | 658 | 0 |
92.28497 | male | 0 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 32,367 | 22,582.9531 | 18,268.5781 | 15 | white | 33.195313 | 56 | 0.377991 | 0.258972 | 1 | 0 | 1 | yes | 0.5 | 0.3 | dnr before sadm | -1 | 109 | 9.798828 | 104 | 12 | 37.59375 | 168 | 1.899902 | 3.799805 | 1.099854 | 143 | 7.379883 | 137 | 25 | 3,430 | null | 1 | <2 mo. follow-up | 1 | 43 | 1 |
74.32996 | male | 0 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | $11-$25k | 0 | 78,641 | 41,373.7188 | 39,718.4688 | 15 | white | 32.398438 | 52 | 0.602905 | 0.495972 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 19 | 103 | 7.5 | 100 | 25 | 36.09375 | 304.75 | 4.299805 | null | 1 | 142 | 7.429688 | 118 | 21 | 2,575 | null | 0 | no(M2 and SIP pres) | 0 | 657 | 0 |
89.00195 | male | 0 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $11-$25k | 0 | 16,165 | 8,656.2188 | 12,441.0078 | 14.5 | white | 23.398438 | 28 | 0.7229 | 0.637939 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 9 | 75 | 14.298828 | 120 | 22 | 36.59375 | 295.1875 | 2.899902 | 0.599976 | 2.399902 | 133 | 7.5 | 114 | 38 | 2,200 | 0 | 0 | no(M2 and SIP pres) | 0 | 657 | 0 |
74.71295 | female | 0 | 5 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 6,499 | 3,311.8633 | 3,244.13867 | 12 | white | 19.398438 | 19 | 0.823975 | 0.712891 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 46 | 13.398438 | 128 | 32 | 36.09375 | 216 | null | null | 0.699951 | 127 | 7.289062 | 268 | 19 | 1,610 | 0 | null | no(M2 and SIP pres) | 0.494751 | 657 | 0 |
83.68195 | female | 1 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 61 | 16,292 | 12,585.8359 | 9,766.38281 | 30 | white | 16.296875 | 17 | 0.67395 | 0.578979 | 1 | 0 | 0 | no | 0.2 | 0.05 | dnr after sadm | 3 | 53 | 31.5 | 65 | 22 | 36.09375 | 98.32812 | 3 | 0.5 | 0.899902 | 140 | 7.469727 | 80 | 36 | 725 | null | 1 | <2 mo. follow-up | 1 | 5 | 1 |
84.71698 | female | 1 | 10 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 14 | null | 0 | 11,188 | 6,340.8047 | 6,025.9375 | 10 | white | 15.298828 | 30 | 0.714966 | 0.556885 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 10 | 59 | 9.898438 | 68 | 25 | 36.09375 | 262.9375 | null | null | 1.699951 | 150 | 7.389648 | 131 | 69 | 1,070 | null | 0 | <2 mo. follow-up | 0 | 10 | 1 |
75.05499 | female | 0 | 7 | COPD | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 10,896 | 5,416.8984 | 5,122.20703 | 9 | white | 14.398438 | 37 | 0.876953 | 0.795898 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 7 | 97 | 3.599609 | 56 | 20 | 36.29688 | 320 | 3.199707 | null | 0.899902 | 141 | 7.399414 | 89 | 26 | 725 | 2 | 1 | <2 mo. follow-up | 1 | 56 | 1 |
75.51294 | male | 0 | 6 | Colon Cancer | Cancer | 4 | 10 | $11-$25k | 0 | 10,102 | 5,214.3555 | 4,136.67969 | 12 | white | 32.59375 | 46 | 0.44696 | 0.135986 | 1 | 1 | 0 | metastatic | 0.6 | 0.5 | dnr after sadm | 3 | 93 | 9.798828 | 80 | 20 | 37 | 340 | null | null | 0.899902 | 146 | 7.389648 | 110 | 37 | 58.695312 | 2 | 1 | <2 mo. follow-up | 1 | 9 | 1 |
69.95197 | female | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 6 | 12 | $25-$50k | 0 | 8,304 | 5,138.1016 | 4,948.04688 | 16 | white | 16.5 | 26 | 0.881958 | 0.803955 | 1 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 6 | 70 | 6.199219 | 80 | 20 | 36.09375 | 383.3125 | 2.599609 | 0.699951 | 1.299805 | 148 | 7.439453 | 120 | 36 | 1,650 | 1 | 1 | no(M2 and SIP pres) | 1 | 651 | 0 |
42.198 | male | 0 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 11 | under $11k | 26 | 8,124 | 5,598.8945 | 4,661.22656 | 22 | other | 25.199219 | 65 | 0.802979 | 0.737915 | 1 | 0 | 0 | no | 0.7 | 0.65 | dnr after sadm | 2 | 53 | 21.398438 | 125 | 34 | 38.29688 | 125 | 3 | 1 | 2.399902 | 152 | 7.439453 | 420 | 55 | 2,661 | null | null | <2 mo. follow-up | 2.992676 | 24 | 1 |
52.099 | male | 0 | 19 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 32,432 | 17,322.9219 | 15,460.4062 | 15 | white | 25.5 | 52 | 0.748901 | 0.603882 | 1 | 0 | 0 | no | 0.75 | 0.6 | dnr after sadm | 13 | 100 | 13.599609 | 100 | 20 | 36.09375 | 268 | 2.299805 | null | 0.899902 | 141 | 7.459961 | 137 | 15 | null | 1 | 5 | no(M2 and SIP pres) | 5 | 634 | 1 |
96.55298 | female | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 4,872 | 2,651.5586 | 2,444.11914 | 7 | white | 16.796875 | 19 | 0.793945 | 0.668945 | 1 | 0 | 0 | no | 0.7 | 0.6 | dnr after sadm | 1 | 103 | 18.796875 | 90 | 25 | 36.09375 | null | null | null | 1.399902 | 138 | null | 188 | 29 | null | 1 | null | no(M2 and SIP pres) | 1.166748 | 448 | 1 |
60.57999 | male | 0 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 7 | under $11k | 0 | 17,258 | 12,425.8438 | 9,322.4375 | 22 | white | 24.199219 | 57 | 0.81897 | 0.758911 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 6 | 123 | 5.799805 | 69 | 42 | 39.39844 | 166 | 2.399902 | null | 1.699951 | 149 | 7.459961 | 245 | 50 | 1,415 | 0 | 0 | SIP>=30 | 0 | 650 | 0 |
77.54999 | female | 1 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 0 | 121,358 | 90,567.5 | 66,565.25 | 37 | white | 37.5 | 78 | 0.442993 | 0.323975 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 14 | 121 | 12.798828 | 107 | 24 | 38.59375 | null | 3.399902 | null | 8.898438 | 133 | null | 116 | 106 | 200 | null | 0 | <2 mo. follow-up | 0 | 22 | 1 |
87.93994 | female | 0 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 10,547 | 6,321.6562 | 6,339.28906 | 6 | white | 26.796875 | 33 | 0.657959 | 0.559937 | 1 | 1 | 1 | no | null | null | dnr before sadm | -1 | 123 | null | 121 | 24 | 35.69531 | null | null | null | 0.899902 | 141 | null | 161 | 18 | 2,425 | null | 6 | null | 6 | 108 | 1 |
80.82098 | male | 0 | 33 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 44 | 66,466 | 41,180.625 | 33,514.75 | 22.5 | black | 19 | 35 | 0.60498 | 0.498962 | 2 | 1 | 1 | yes | 0.5 | 0.4 | dnr after sadm | 16 | 55 | 7.699219 | 72 | 35 | 36.89844 | 171.65625 | null | null | 0.699951 | 140 | 7.419922 | 112 | 16 | 1,470 | null | 0 | adl>=4 (>=5 if sur) | 0 | 160 | 1 |
52.405 | male | 0 | 15 | MOSF w/Malig | ARF/MOSF | 2 | 14 | under $11k | 0 | 73,204 | 51,713.1562 | 37,489.0625 | 24.666656 | white | 31 | 38 | 0.483948 | 0.36499 | 5 | 0 | 0 | yes | 0.1 | 0 | no dnr | 15 | 63 | 6.699219 | 64 | 20 | 36.59375 | null | 4 | null | 1 | 142 | null | 106 | 9 | 3,625 | null | 0 | no(M2 and SIP pres) | 0 | 244 | 1 |
41.202 | female | 0 | 32 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 129,721 | 82,183.5 | 56,350.5625 | 38 | white | 36.5 | 71 | 0.688965 | 0.595947 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 32 | 44 | 21.898438 | 105 | 10 | 38.5 | 92 | 2.699707 | null | 2.599609 | 137 | 7.419922 | 173 | 55 | 953 | null | null | null | 2.36084 | 646 | 0 |
66.28595 | female | 0 | 12 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 16,697 | 9,707.1875 | 10,306.0625 | 8.5 | white | 16.199219 | 35 | 0.893921 | 0.822998 | 1 | 0 | 0 | no | 0.75 | 0.5 | dnr after sadm | 1 | 47 | 6.5 | 80 | 20 | 36.09375 | 504.75 | 3 | 0.299988 | 0.799927 | 131 | 7.479492 | 72 | 3 | 1,200 | 2 | 1 | <2 mo. follow-up | 1 | 43 | 1 |
87.06396 | female | 0 | 4 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 5,038 | 2,673.8769 | 2,827.80859 | 9 | white | 16.796875 | 18 | 0.785889 | 0.656982 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 100 | 6.799805 | 61 | 24 | 36.09375 | 159.0625 | 4.299805 | 0.299988 | 1.099854 | 133 | 7.299805 | 229 | 15 | 1,500 | null | null | adl>=4 (>=5 if sur) | 3.17627 | 70 | 1 |
29.23999 | male | 0 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | under $11k | 0 | 5,007 | 2,405.1856 | 2,665.04883 | null | white | 22.5 | 33 | 0.909912 | 0.876953 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 120 | 10.5 | 78 | 4 | 38.69531 | 151 | null | null | 0.899902 | 143 | 7.439453 | 130 | 21 | 1,730 | null | null | no(M2 and SIP pres) | 1.826416 | 643 | 0 |
62.25299 | male | 0 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 19 | null | 0 | 47,166 | 34,499.5625 | 27,598.8594 | 29.666656 | white | 26.597656 | 48 | 0.778931 | 0.706909 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 16 | 72 | 6.599609 | 80 | 20 | 36.59375 | 385.6875 | null | null | 1.599854 | 131 | 7.429688 | 118 | 40 | 1,730 | null | 3 | SIP>=30 | 3 | 642 | 0 |
68.75598 | male | 0 | 16 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 39,370 | 21,827.7031 | 19,721.0938 | 18 | white | 14.398438 | 16 | 0.886963 | 0.810913 | 3 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 16 | 78 | 5 | 92 | 12 | 35.39844 | null | 3.299805 | 0.199982 | 0.599976 | 140 | null | 131 | 5 | null | 1 | 1 | no(M2 and SIP pres) | 1 | 642 | 0 |
47.379 | male | 0 | 5 | Colon Cancer | Cancer | 1 | null | null | 0 | 5,139 | 3,095.4082 | 4,275.61719 | 11 | white | 15.5 | 14 | 0.862915 | 0.69397 | 1 | 0 | 0 | metastatic | 0.95 | 0.5 | no dnr | 5 | 107 | 12.398438 | 60 | 20 | 35.39844 | 290.4375 | null | null | 1.699951 | 142 | 7.369141 | 53 | 43 | 1,300 | null | null | null | 2.240723 | 216 | 1 |
51.64398 | male | 0 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 18 | >$50k | 0 | 54,163 | 35,252 | 27,047.6562 | 35.666657 | white | 42.796875 | 103 | 0.379944 | 0.260986 | 1 | 0 | 0 | yes | 0.2 | 0.2 | no dnr | 16 | 83 | 11.298828 | 120 | 20 | 38.19531 | null | 3.699707 | 2.299805 | 1.399902 | 133 | null | 97 | 20 | 2,400 | null | null | no(M2 and SIP pres) | 2.358398 | 640 | 0 |
53.02899 | male | 0 | 6 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 10,443 | 5,390.8398 | 5,308.57812 | 10 | black | 19.699219 | 28 | 0.681885 | 0.386963 | 1 | 0 | 0 | metastatic | 1 | 0.5 | no dnr | 6 | 49 | 10.699219 | 60 | 10 | 39 | 220 | 2.099609 | 0.699951 | 4.699219 | 160 | 7.349609 | 150 | 82 | 2,000 | 0 | null | <2 mo. follow-up | 0.494751 | 36 | 1 |
90.42798 | female | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 3,956 | 2,251.0762 | 2,230.45898 | 8 | white | 17.296875 | 15 | 0.810913 | 0.694946 | 1 | 1 | 0 | no | 0.95 | 0.85 | no dnr | 4 | 111 | 11.099609 | 117 | 26 | 36.19531 | 127 | null | null | 1.899902 | 142 | 7.449219 | 103 | 58 | 1,480 | 0 | null | no(M2 and SIP pres) | 0.494751 | 637 | 0 |
76.54797 | male | 0 | 7 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 7,034 | 4,044.625 | 3,867.28906 | 10 | white | 16.597656 | 24 | 0.863892 | 0.774902 | 1 | 1 | 0 | no | null | null | no dnr | 7 | 97 | 6.299805 | 76 | 24 | 36.59375 | 115 | 4.199219 | 0.899902 | 1.5 | 137 | 7.199219 | 106 | 26 | 900 | 1 | 0 | no(M2 and SIP pres) | 0 | 637 | 0 |
80.75 | female | 1 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | $11-$25k | 0 | 45,475 | 29,121.9219 | 26,887.3281 | 29 | black | 24.296875 | 41 | 0.661987 | 0.563965 | 16 | 1 | 0 | no | 0.2 | 0.1 | dnr after sadm | 1 | 73 | 7.5 | 100 | 25 | 36.09375 | 217.375 | null | null | 0.899902 | 141 | 7.369141 | 139 | 16 | null | null | 0 | <2 mo. follow-up | 0 | 5 | 1 |
49.68698 | male | 0 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 0 | 48,180 | 28,100.25 | 23,259.6562 | 24 | white | 33.898438 | 47 | 0.699951 | 0.609985 | 1 | 0 | 0 | no | 0.78 | 0.6 | no dnr | 23 | 125 | 13.398438 | 61 | 8 | 38.19531 | 242.5 | 3.599609 | null | 0.799927 | 140 | 7.589844 | 112 | 14 | 1,560 | 0 | null | no(M2 and SIP pres) | 0.494751 | 633 | 0 |
79.78894 | female | 0 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 0 | 76,279 | 43,290.6875 | 27,250.4219 | 28.333328 | white | 16.097656 | 33 | 0.809937 | 0.746948 | 19 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 19 | 100 | 9.099609 | 60 | 20 | 37 | null | 2.399902 | 0.899902 | 1.299805 | 143 | null | 114 | 16 | 280 | null | 1 | no(M2 and SIP pres) | 1 | 632 | 0 |
53.58499 | male | 0 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 16 | >$50k | 0 | 12,397 | 6,571.5312 | 5,340.19922 | 12.5 | white | 19 | 31 | 0.836914 | 0.733887 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 8 | 80 | 4.299805 | 70 | 30 | 36.09375 | 228.5625 | 3.899902 | 1.099854 | 1.199951 | 140 | 7.379883 | 152 | 35 | 1,075 | 0 | 0 | no(M2 and SIP pres) | 0 | 632 | 0 |
91.01996 | female | 0 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 37 | 11,767 | 6,400.082 | 6,496.94922 | 18 | white | 14.699219 | 21 | 0.75293 | 0.674927 | 1 | 0 | 1 | no | 0.9 | 0.9 | dnr before sadm | -1 | 73 | 7.299805 | 80 | 20 | 35.59375 | null | 2.399902 | null | 1.699951 | 132 | null | 351 | 61 | 1,125 | null | null | SIP>=30 | 5.137695 | 96 | 1 |
74.70996 | female | 1 | 5 | Coma | Coma | 1 | 8 | $11-$25k | 94 | 18,728 | 13,579.5156 | 11,059.2188 | 31 | white | 22.5 | 30 | 0.096985 | 0.057999 | 2 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 4 | 80 | 11.398438 | 80 | 25 | 36.69531 | 276 | null | null | 1 | 136 | 7.479492 | 227 | 20 | 2,525 | null | null | <2 mo. follow-up | 2.498535 | 5 | 1 |
59.82498 | female | 0 | 12 | Colon Cancer | Cancer | 4 | null | null | 0 | 15,538 | 8,949.1797 | 6,965.76953 | 11 | null | 37.695313 | 38 | 0.357971 | 0.077988 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 1 | 53 | 11.898438 | 100 | 15 | 38.29688 | null | 1.799805 | 0.599976 | 7.299805 | 138 | null | 69 | 68 | 0 | null | null | <2 mo. follow-up | 3.479492 | 18 | 1 |
79.49597 | female | 0 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | null | 0 | 37,583 | 23,426.4375 | 20,075.7812 | 20.333328 | white | 35.195313 | 52 | 0.494995 | 0.377991 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 15 | 57 | 11.699219 | 80 | 20 | 36.09375 | null | 2.399902 | 7.399414 | 1.5 | 137 | null | 227 | 51 | null | 0 | null | no(M2 and SIP pres) | 0.494751 | 629 | 0 |
35.17599 | male | 0 | 18 | MOSF w/Malig | ARF/MOSF | 1 | 14 | >$50k | 0 | 86,623 | 45,066.5312 | 43,258.9375 | 21 | white | 27.199219 | 52 | 0.589966 | 0.480957 | 10 | 0 | 0 | yes | 0.4 | 0.2 | no dnr | 18 | 107 | 3 | 70 | 30 | 36.09375 | null | null | null | 0.899902 | 140 | null | 98 | 16 | 1,800 | 0 | 4 | no(M2 and SIP pres) | 4 | 196 | 1 |
66.58496 | male | 0 | 31 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 124,293 | 70,849.0625 | 67,079.6875 | 40 | white | 21.597656 | 42 | 0.833984 | 0.776978 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 31 | 49 | 9.898438 | 70 | 16 | 36.09375 | 371.375 | null | 0.599976 | 14.5 | 135 | 7.339844 | 88 | 83 | 0 | 0 | 1 | adl>=4 (>=5 if sur) | 1 | 196 | 1 |
86.10797 | male | 0 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 26,338 | 17,204.7031 | 14,160.6172 | 27 | white | 32.398438 | 40 | 0.482971 | 0.36499 | 3 | 0 | 0 | no | 0.95 | 0.85 | dnr after sadm | 1 | 111 | 27.199219 | 119 | 10 | 36 | 66 | 2.299805 | 0.599976 | 7.199219 | 135 | 7.489258 | 184 | 79 | 345 | 0 | 1 | no(M2 and SIP pres) | 1 | 625 | 0 |
75.44696 | female | 0 | 32 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 0 | 87,543 | 62,266.3438 | 51,062.6562 | 33 | white | 32.695313 | 46 | 0.586914 | 0.477966 | 1 | 0 | 1 | no | 0.5 | 0.5 | dnr after sadm | 4 | 50 | 6.099609 | 60 | 20 | 35.59375 | null | null | null | 1.399902 | 136 | null | 145 | 42 | null | null | null | null | 3.80957 | 622 | 0 |
89.09198 | male | 0 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 14,379 | 9,627.0469 | 8,098.1875 | 8.5 | black | 21.597656 | 34 | 0.699951 | 0.609985 | 1 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 7 | 109 | 12.398438 | 72 | 4 | 38.79688 | 295 | 2.199707 | null | 1.299805 | 139 | 7.429688 | 274 | 19 | 2,160 | null | null | null | 3.843262 | 623 | 0 |
85.70795 | male | 0 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | $25-$50k | 0 | 55,561 | 31,941 | 39,482.3125 | 33.666657 | white | 18.597656 | 36 | 0.813965 | 0.751953 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 18 | 113 | 13.199219 | 110 | 10 | 36.09375 | 91.42188 | 2.099609 | null | 0.599976 | 137 | 7.429688 | 180 | 20 | 8,550 | null | 5 | adl>=4 (>=5 if sur) | 5 | 623 | 0 |
77.23798 | male | 1 | 29 | MOSF w/Malig | ARF/MOSF | 3 | 15 | $11-$25k | 0 | 84,604 | 49,319.5625 | 46,697.875 | 17 | hispanic | 18.597656 | 29 | 0.724976 | 0.640991 | 8 | 0 | 0 | yes | 0.8 | 0.1 | dnr after sadm | 1 | 51 | 2.599609 | 155 | 10 | 38.19531 | 125 | 1.599854 | 1 | 0.799927 | 143 | 7.259766 | 73 | 21 | 2,640 | 2 | 1 | <2 mo. follow-up | 1 | 29 | 1 |
49.875 | male | 0 | 16 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 57,210 | 34,996.625 | 32,341.1406 | 30.666656 | white | 23.097656 | 34 | 0.871948 | 0.786987 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 16 | 73 | 9.298828 | 70 | 25 | 36.69531 | 260 | null | null | 0.799927 | 141 | 7.359375 | 213 | 27 | 600 | null | 0 | SIP>=30 | 0 | 235 | 1 |
88.487 | female | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | under $11k | 0 | 5,350 | 3,153.6074 | 3,773.96875 | 15 | white | 20.097656 | 19 | 0.776978 | 0.643921 | 1 | 0 | 0 | no | 0.95 | 0.6 | no dnr | 6 | 73 | 11.099609 | 70 | 20 | 36.09375 | 678.25 | null | null | 1.199951 | 142 | 7.279297 | 155 | 38 | null | 2 | null | no(M2 and SIP pres) | 1.838867 | 498 | 1 |
63.064 | male | 0 | 20 | COPD | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 44,135 | 30,358.0156 | 26,456.7188 | 22.666656 | white | 23.398438 | 24 | 0.834961 | 0.730957 | 1 | 0 | 0 | no | 0.9 | 0.7 | dnr after sadm | 1 | 57 | 14.599609 | 124 | 10 | 39.09375 | 368.3125 | 4.399414 | 0.5 | 1 | 136 | 7.5 | 137 | 11 | null | null | 0 | SIP>=30 | 0 | 618 | 0 |
77.84296 | male | 0 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 16,510 | 11,070.5391 | 10,050.3594 | 20 | white | 29 | 45 | 0.662964 | 0.564941 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 10 | 67 | 7.5 | 73 | 12 | 36.29688 | 152 | 3.099609 | 0.399963 | 5.599609 | 131 | 7.389648 | 317 | 146 | 2,745 | 0 | 0 | no(M2 and SIP pres) | 0 | 618 | 0 |
35.13998 | female | 1 | 8 | MOSF w/Malig | ARF/MOSF | 1 | 15 | >$50k | 0 | 134,773 | 77,402.1875 | 58,795.5 | 45.5 | white | 37.695313 | 77 | 0.266968 | 0.159973 | 22 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 7 | 118 | 8.898438 | 68 | 24 | 39 | 366.625 | null | null | 1.399902 | 140 | 7.459961 | 96 | 26 | 2,100 | null | 1 | <2 mo. follow-up | 1 | 8 | 1 |
77.862 | female | 0 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 15 | $11-$25k | 0 | 50,395 | 29,363.4375 | 26,245.6719 | 23.333328 | white | 28.597656 | 35 | 0.600952 | 0.493958 | 1 | 1 | 0 | yes | 0.8 | 0.65 | no dnr | 17 | 69 | 6.299805 | 72 | 20 | 35.79688 | null | null | 0.5 | 1.199951 | 142 | null | 106 | 14 | 2,875 | null | 0 | no(M2 and SIP pres) | 0 | 448 | 1 |
79.59198 | female | 0 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 81,465 | 45,749.0625 | 43,473.0938 | 39 | white | 30.199219 | 54 | 0.573975 | 0.462952 | 4 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 24 | 111 | 0.399963 | 170 | 28 | 36.19531 | 135 | 2.299805 | 2.099609 | 7.799805 | 135 | 7.349609 | 90 | 103 | 1,660 | null | 3 | no(M2 and SIP pres) | 3 | 615 | 0 |
66.10297 | female | 0 | 3 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 7,201 | 5,917.7344 | 4,878.83984 | null | black | 18.898438 | 46 | 0.870972 | 0.785889 | 1 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 3 | 87 | 7.099609 | 80 | 20 | 36.69531 | null | null | 0.399963 | 3.5 | 142 | null | 88 | 70 | 1,375 | 0 | null | no(M2 and SIP pres) | 0.494751 | 204 | 1 |
53.55499 | female | 0 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | >$50k | 0 | 65,863 | 47,683.4688 | 36,288.7188 | 34 | white | 23.699219 | 35 | 0.845947 | 0.792969 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 21 | 97 | 7.799805 | 70 | 25 | 36.09375 | null | null | null | 0.799927 | 139 | null | 162 | 13 | 1,600 | null | 1 | SIP>=30 | 1 | 614 | 0 |
61.952 | female | 1 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 44 | 42,843 | 32,285.8125 | 26,218.7344 | 22.333328 | null | 25.898438 | 60 | 0.642944 | 0.541992 | 1 | 0 | 0 | no | 0.05 | 0 | dnr after sadm | 8 | 70 | 3.799805 | 80 | 20 | 35.59375 | null | 3.899902 | null | 1.799805 | 137 | null | 112 | 33 | null | null | null | <2 mo. follow-up | 2.327637 | 14 | 1 |
84.57794 | male | 0 | 13 | CHF | COPD/CHF/Cirrhosis | 2 | 22 | null | 0 | 14,980 | 8,515 | 7,564.96875 | 10.5 | white | 22.699219 | 31 | 0.750977 | 0.606934 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 13 | 63 | 30.097656 | 75 | 24 | 36.19531 | null | 2.5 | null | 5.099609 | 134 | null | 303 | 300 | 2,155 | 1 | 4 | SIP>=30 | 4 | 613 | 0 |
81.06494 | male | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | >$50k | 0 | 5,775 | 3,203.0195 | 3,340.48828 | 17 | white | 19.5 | 17 | 0.815918 | 0.701904 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 6 | 111 | 13 | 110 | 34 | 39.59375 | 162 | null | null | 1.5 | 135 | 7.439453 | 158 | 37 | 3,650 | 0 | null | <2 mo. follow-up | 0.494751 | 36 | 1 |
58.168 | female | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | null | 0 | 6,601 | 3,433.3731 | 2,950.85938 | 18 | black | 18.898438 | 35 | 0.860962 | 0.770996 | 1 | 1 | 0 | yes | 0.85 | 0.85 | no dnr | 5 | 110 | 5.699219 | 44 | 34 | 36.19531 | 79 | 2.599609 | 0.699951 | 1.899902 | 138 | 7.359375 | 132 | 27 | 1,675 | 1 | null | no(M2 and SIP pres) | 1.166748 | 347 | 1 |
71.64398 | male | 0 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | >$50k | 0 | 49,989 | 27,934.75 | 27,841.6719 | 24 | white | 29.597656 | 37 | 0.572998 | 0.461975 | 3 | 0 | 0 | yes | 0.9 | 0.7 | no dnr | 17 | 56 | 10.5 | 70 | 6 | 37.79688 | 232.5 | 2 | 0.199982 | 1.199951 | 143 | 7.479492 | 152 | 21 | 3,200 | null | null | <2 mo. follow-up | 2.953613 | 48 | 1 |
63.76999 | male | 0 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 22 | >$50k | 0 | 69,599 | 35,332.0312 | 44,057.0312 | 22.333328 | white | 17.398438 | 33 | 0.884888 | 0.843994 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 18 | 83 | 6 | 80 | 20 | 38.29688 | null | 3 | 4.5 | 1.699951 | 133 | null | 95 | 39 | 800 | 0 | 0 | no(M2 and SIP pres) | 0 | 548 | 1 |
58.60397 | male | 0 | 37 | MOSF w/Malig | ARF/MOSF | 5 | 22 | $25-$50k | 0 | 141,401 | 91,900.25 | 73,641.5625 | 35.25 | white | 35.898438 | 48 | 0.353943 | 0.237 | 3 | 0 | 0 | yes | 0.6 | 0.5 | no dnr | 37 | 112 | 8.398438 | 76 | 22 | 36 | null | null | null | 1.199951 | 137 | null | 93 | 25 | 1,325 | null | 1 | adl>=4 (>=5 if sur) | 1 | 563 | 1 |
44.49597 | female | 0 | 6 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 5,962 | 3,463.832 | 4,775.07812 | 6 | black | 29.597656 | 50 | 0.455994 | 0.142975 | 1 | 0 | 0 | metastatic | 0.15 | 0.01 | dnr after sadm | 2 | 116 | 16.796875 | 118 | 32 | 39.09375 | 250 | 4 | null | 0.799927 | 145 | 7.40918 | 315 | 18 | 887 | null | null | <2 mo. follow-up | 2.540527 | 16 | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.